ETH News

Global warming causes extreme temperatures – this is clear to most, but few realize that both droughts and heavy rains are symptomatic of a climate in crisis. Sonia Seneviratne explains the far-reaching impacts of climate extremes.

For the first time, an international team of researchers has shown that countless tiny ice quakes take place in one of Greenland's mightiest ice streams. This finding will allow the flowing of the ice stream and associated changes in sea level to be estimated more accurately.

Body weight and body mass index alone are not enough to predict whether someone will develop a metabolic disease. A new atlas of cells in fat tissue could help to explain why some overweight people stay healthy, while others do not.

Medical research needs unresolved issues from clinical practice, says ETH Vice President Christian Wolfrum. He explains in an interview how cooperation between ETH research and hospitals can be improved and why ETH intends to pool its activities in medical research.

The University of St.Gallen (HSG) and ETH Zurich are jointly launching the “ETH-HSG Manufacturing Alliance”. In doing so, they want to strengthen the competitiveness of Swiss industry and promote young talent. The alliance combines the strengths of the two universities and provides new impetus in research and practice.

ETH Zurich’s CAS programme in Applied Technology in Energy provides a deeper understanding of the energy system. It enables participants to play a part in shaping the energy future of their company or industry and therefore in achieving the climate target of net zero.

With 37 new spin-offs, ETH Zurich continues its long-term upward trend in the launch of new companies from its research. Start-ups in the fields of artificial intelligence and biotechnology were particularly well represented.

Every second woman and every eighth man suffer from urinary tract infections. These are painful and can recur with serious health consequences. Pioneer Fellow Giorgia Greter has a solution.

Researchers aim to use vibrations to stimulate bone growth. Now, a new study paves the way for developing new therapies that may one day benefit patients suffering from bone fractures and age-related bone loss.

Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases formation.